Triprolidine Shortage Update: What Patients Need to Know in 2026

As of 2026, the FDA has not declared an active shortage of triprolidine. However, patients across the US continue to report difficulty finding it — especially in standalone liquid formulations for children, or the specific combination form with pseudoephedrine that was once sold as Actifed. This update explains exactly what's happening with triprolidine availability and what patients can do about it.

Is There an Official Triprolidine Shortage?

No. As of early 2026, triprolidine does not appear on the FDA's official drug shortage database. The FDA only lists drugs when manufacturing disruptions, supply chain failures, or increased demand outpace production. Triprolidine's manufacturing has been consistent across multiple generic manufacturers, and no major supply interruption has been reported.

That said, "no shortage" doesn't always mean "easy to find." The confusion around triprolidine has much deeper roots — rooted in regulatory changes from 2005 and a market fragmentation that left patients unsure of what to ask for.

The 2006 Actifed Reformulation: The Origin of the Confusion

For many patients, the "triprolidine problem" began in 2006. The Combat Methamphetamine Epidemic Act of 2005 required pseudoephedrine-containing products to be sold only from behind the pharmacy counter. Many manufacturers of Actifed — the beloved triprolidine/pseudoephedrine combination — chose to reformulate their products rather than move them behind the counter.

The reformulated "Actifed" replaced triprolidine and pseudoephedrine with phenylephrine and chlorpheniramine — ingredients considered less effective by many pharmacists and patients. The original formula survived only in generic form, under names like Aprodine, Aphedrid, and Genac. These generics remain available today but are only found behind the pharmacy counter and are not heavily advertised — leading many patients to believe the product no longer exists.

Why Standalone Triprolidine Is Harder to Find

Standalone triprolidine — products like Histex PD Drops and Zymine syrup, primarily used in pediatric patients — has a limited market demand compared to combination products. This means fewer manufacturers produce it and fewer pharmacies stock it consistently. Even large chain pharmacies may not carry it at every location.

Factors that affect standalone triprolidine availability include:

Small number of US manufacturers producing standalone pediatric triprolidine solutions

Low prescription volume (most antihistamines prescribed are second-generation)

FDA warning against use in children under 2 reducing pediatric market

Pharmacy ordering decisions based on local demand — some stores may simply not order it

What This Means for Patients in 2026

The practical reality is this: triprolidine is available, but you may have to work to find it at your specific pharmacy. Here's what matters most:

Combination triprolidine/pseudoephedrine is available behind the counter at most major chain pharmacies

Standalone pediatric triprolidine solutions require calling ahead or using a service to check pharmacy stock

Your pharmacist can often order it if they don't have it in stock — give them at least 24–48 hours

If you need it urgently, calling multiple pharmacies or using medfinder to search is the fastest path

How to Check Triprolidine Availability Near You

The most efficient approach is to use medfinder. Enter your medication details and location, and medfinder contacts pharmacies near you to find which ones have it in stock. You'll receive a text with results — no need to spend 20 minutes on hold with multiple pharmacies.

Should I Switch Medications?

If triprolidine is consistently unavailable at pharmacies near you, it may be worth discussing alternatives with your doctor. Second-generation antihistamines like cetirizine (Zyrtec) or loratadine (Claritin) are generally easier to find and require only once-daily dosing. Read our full guide to triprolidine alternatives to understand your options.